Labo Euromedis (XPAR:ALEMG) EV-to-EBITDA : 0.15 (As of Jun. 12, 2024)

Labo Euromedis EV-to-EBITDA Chart

Labo Euromedis Annual Data
	Trend	Jul13	Jul14	Jul15	Jul16	Jul17	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBITDA		Get a 7-Day Free Trial					-16.49	1.26	3.53	-0.06	0.29

Labo Euromedis Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															3.53	-	-0.06	-	-

Competitive Comparison of Labo Euromedis's EV-to-EBITDA

For the Medical Devices subindustry, Labo Euromedis's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's EV-to-EBITDA falls into.

Labo Euromedis EV-to-EBITDA Calculation

Labo Euromedis's EV-to-EBITDA for today is calculated as:

Labo Euromedis's current Enterprise Value is €3.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €24.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis  (XPAR:ALEMG) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Labo Euromedis's PE Ratio for today is calculated as:

Labo Euromedis's share price for today is €4.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €4.651.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Labo Euromedis EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis (XPAR:ALEMG) Business Description